Overview
Corteva, Inc., headquartered in the United States, is a prominent player in the global agriculture industry. The company is dedicated to enhancing the sustainability and productivity of farming through a diversified portfolio of seed and crop protection solutions. Key projects at Corteva focus on developing innovative biotechnology and chemistry to boost crop yield, combat pests and diseases, and improve resistance to environmental stresses. Through strategic partnerships and continuous research and development, Cortievalso emphasizes digital agricultural solutions to optimize farm management and productivity. The firm stands out for its commitment to environmental sustainability and the adaptation of modern agricultural practices to meet the evolving demands of food production and resource conservation.
Basic Stats
The share price of Corteva, Inc. as of 10 July 2025 is € 64,41 / share. The market cap (or net worth) of Corteva, Inc. as of 10 July 2025 is € 43.791,01 MM.
The Factor Analysis chart (below right) shows a view of Corteva, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 43,791.01 MM |
| EV | |
| Shares Out. | 679.88 MM |
| Earnings Date | |
| EPS (TTM) | 1.67 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-09-02 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.06 |
| Beta | -0.93 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.03 |
| ROE | 0.04 |
| ROIC | 0.04 |
| CROIC | 0.01 |
| OCROIC | 0.09 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 97.51 /100 |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Corteva, Inc. is € 67,17. The forecasts range from a low of € 52,52 to a high of € 77,70. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
| Record Date | Projection Date | High | Low | Median | Average |
|---|---|---|---|---|---|
| 2023-04-04 | 2024-04-04 | 77.70 | 52.52 | 67.32 | 67.17 |
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Corteva, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-06-18 | Mizuho | Buy | Buy | Maintains |
| 2024-06-12 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-06-07 | OTR Global | Mixed | Negative | Downgrade |
| 2024-05-06 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-05-06 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-05-03 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-05-03 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-05-03 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-05-03 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-05-02 | Mizuho | Buy | Buy | Maintains |
| 2024-04-16 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-12 | JP Morgan | Overweight | Neutral | Downgrade |
| 2024-04-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-09 | Keybanc | Overweight | Overweight | Maintains |
| 2024-03-01 | Wolfe Research | Outperform | Initiate | |
| 2024-02-12 | Loop Capital | Hold | Buy | Upgrade |
| 2024-02-02 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-02 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-02-02 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-02-02 | Keybanc | Overweight | Overweight | Maintains |
| 2024-02-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-02 | Exane BNP Paribas | Underperform | Neutral | Upgrade |
| 2024-02-01 | Mizuho | Buy | Buy | Maintains |
| 2024-01-29 | Roth MKM | Buy | Buy | Maintains |
| 2024-01-11 | UBS | Buy | Buy | Maintains |
| 2023-11-27 | Berenberg | Buy | Hold | Downgrade |
| 2023-11-22 | Roth MKM | Buy | Buy | Maintains |
| 2023-11-14 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2023-11-10 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-11-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-11-10 | Keybanc | Overweight | Overweight | Maintains |
| 2023-10-30 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-10-30 | Fermium Research | Outperform | Outperform | Maintains |
| 2023-10-30 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-10-24 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2023-10-23 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-10-20 | Oppenheimer | Perform | Outperform | Upgrade |
| 2023-10-10 | Mizuho | Buy | Buy | Maintains |
| 2023-09-05 | UBS | Neutral | Buy | Upgrade |
| 2023-08-17 | Argus Research | Buy | Buy | Maintains |
| 2023-08-14 | Barclays | Overweight | Overweight | Maintains |
| 2023-08-07 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-08-07 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-08-07 | Mizuho | Buy | Buy | Maintains |
| 2023-08-07 | Keybanc | Overweight | Overweight | Maintains |
| 2023-08-04 | Credit Suisse | Outperform | Outperform | Reiterate |
| 2023-07-25 | Redburn Partners | Buy | Neutral | Downgrade |
| 2023-07-13 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-11 | Keybanc | Overweight | Overweight | Maintains |
| 2023-06-28 | Canaccord Genuity | Buy | Initiate | |
| 2023-06-21 | Morgan Stanley | Overweight | Reiterate | |
| 2023-06-01 | Barclays | Overweight | Overweight | Maintains |
| 2023-05-22 | Vertical Research | Hold | Buy | Upgrade |
| 2023-05-05 | Wells Fargo | Overweight | Maintains | |
| 2023-05-05 | Mizuho | Buy | Maintains | |
| 2023-04-21 | Mizuho | Buy | Maintains | |
| 2023-02-03 | Wells Fargo | Overweight | Maintains | |
| 2023-02-03 | Citigroup | Buy | Maintains | |
| 2023-02-03 | Keybanc | Overweight | Maintains | |
| 2023-01-20 | Citigroup | Buy | Maintains | |
| 2023-01-19 | Wells Fargo | Overweight | Initiate | |
| 2023-01-12 | Mizuho | Buy | Maintains | |
| 2023-01-11 | Morgan Stanley | Overweight | Maintains | |
| 2023-01-11 | B of A Securities | Underperform | Neutral | Upgrade |
| 2022-11-17 | Barclays | Overweight | Maintains | |
| 2022-11-16 | UBS | Buy | Neutral | Downgrade |
| 2022-11-15 | Loop Capital | Buy | Hold | Downgrade |
| 2022-11-07 | RBC Capital | Outperform | Maintains | |
| 2022-11-07 | Mizuho | Buy | Maintains | |
| 2022-11-07 | BMO Capital | Outperform | Maintains | |
| 2022-11-04 | Credit Suisse | Outperform | Maintains | |
| 2022-10-20 | Mizuho | Buy | Maintains | |
| 2022-09-22 | UBS | Buy | Maintains | |
| 2022-09-15 | Deutsche Bank | Buy | Maintains | |
| 2022-09-14 | BMO Capital | Outperform | Maintains | |
| 2022-09-14 | Keybanc | Overweight | Maintains | |
| 2022-08-09 | RBC Capital | Outperform | Maintains | |
| 2022-08-08 | Mizuho | Buy | Maintains | |
| 2022-08-08 | Citigroup | Buy | Maintains | |
| 2022-08-08 | JP Morgan | Neutral | Overweight | Upgrade |
| 2022-07-29 | Mizuho | Buy | Maintains | |
| 2022-07-14 | Credit Suisse | Outperform | Initiate | |
| 2022-06-01 | Barclays | Overweight | Initiate | |
| 2022-05-31 | Deutsche Bank | Buy | Maintains | |
| 2022-05-23 | Argus Research | Buy | Maintains | |
| 2022-05-06 | Keybanc | Overweight | Maintains | |
| 2022-05-06 | JP Morgan | Overweight | Neutral | Downgrade |
| 2022-04-29 | Mizuho | Buy | Maintains | |
| 2022-04-14 | Vertical Research | Buy | Hold | Downgrade |
| 2022-04-14 | Loop Capital | Hold | Buy | Upgrade |
| 2022-04-05 | Keybanc | Overweight | Maintains | |
| 2022-03-22 | Citigroup | Buy | Maintains | |
| 2022-02-04 | Keybanc | Overweight | Maintains | |
| 2021-11-15 | Morgan Stanley | Overweight | Maintains | |
| 2021-11-05 | Keybanc | Overweight | Maintains | |
| 2021-10-18 | Loop Capital | Buy | Hold | Downgrade |
| 2021-10-13 | Mizuho | Buy | Initiate | |
| 2021-10-08 | Roth Capital | Buy | Initiate | |
| 2021-09-01 | Berenberg | Buy | Initiate | |
| 2021-08-09 | Monness, Crespi, Hardt | Sell | Neutral | Upgrade |
| 2021-08-09 | Barclays | Equal-Weight | Maintains | |
| 2021-08-09 | RBC Capital | Outperform | Maintains | |
| 2021-05-10 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-19 | Loop Capital | Hold | Buy | Upgrade |
| 2021-04-12 | Keybanc | Overweight | Maintains | |
| 2021-02-05 | Credit Suisse | Neutral | Maintains | |
| 2021-02-05 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-05 | JP Morgan | Neutral | Overweight | Upgrade |
| 2021-02-05 | KeyBanc | Overweight | Maintains | |
| 2021-01-21 | Redburn | Buy | Neutral | Downgrade |
| 2021-01-15 | KeyBanc | Overweight | Maintains | |
| 2020-12-14 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2020-11-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-09 | KeyBanc | Overweight | Maintains | |
| 2020-11-06 | Credit Suisse | Neutral | Maintains | |
| 2020-11-06 | BMO Capital | Outperform | Maintains | |
| 2020-10-19 | Exane BNP Paribas | Outperform | Underperform | Downgrade |
| 2020-10-07 | KeyBanc | Overweight | Maintains | |
| 2020-08-11 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2020-08-10 | B of A Securities | Buy | Neutral | Downgrade |
| 2020-08-07 | Credit Suisse | Neutral | Maintains | |
| 2020-07-13 | B of A Securities | Underperform | Buy | Upgrade |
| 2020-06-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-05-11 | Barclays | Equal-Weight | Maintains | |
| 2020-05-11 | RBC Capital | Outperform | Maintains | |
| 2020-05-11 | B of A Securities | Neutral | Underperform | Downgrade |
| 2020-05-08 | Deutsche Bank | Buy | Maintains | |
| 2020-05-08 | Citigroup | Buy | Maintains | |
| 2020-05-05 | Credit Suisse | Neutral | Maintains | |
| 2020-04-17 | B of A Securities | Buy | Neutral | Downgrade |
| 2020-04-17 | Loop Capital | Sell | Hold | Upgrade |
| 2020-04-01 | Exane BNP Paribas | Neutral | Outperform | Upgrade |
| 2020-03-31 | Susquehanna | Neutral | Positive | Upgrade |
| 2020-03-30 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-03-26 | KeyBanc | Sector Weight | Initiate | |
| 2020-03-19 | Edward Jones | Hold | Buy | Upgrade |
| 2020-02-05 | Susquehanna | Positive | Neutral | Downgrade |
| 2020-01-31 | JP Morgan | Underweight | Neutral | Upgrade |
| 2020-01-23 | Bernstein | Market Perform | Outperform | Upgrade |
| 2020-01-23 | Loop Capital | Hold | Sell | Downgrade |
| 2020-01-17 | JP Morgan | Neutral | Underweight | Downgrade |
| 2019-12-19 | UBS | Buy | Maintains | |
| 2019-11-12 | Redburn | Buy | Initiate | |
| 2019-11-01 | JP Morgan | Overweight | Neutral | Downgrade |
| 2019-10-11 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2019-10-09 | Citigroup | Buy | Maintains | |
| 2019-08-19 | Citi | Neutral | Buy | Upgrade |
| 2019-08-09 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2019-07-17 | Monness Crespi Hardt | Sell | Initiate | |
| 2019-07-02 | Loop Capital | Hold | Initiate | |
| 2019-07-01 | Barclays | Equal-Weight | Initiate | |
| 2019-06-20 | RBC Capital | Sector Perform | Initiate | |
| 2019-06-17 | Deutsche Bank | Hold | Buy | Upgrade |
| 2019-06-10 | Nomura | Neutral | Initiate | |
| 2019-06-06 | Bernstein | Market Perform | Initiate | |
| 2019-06-04 | UBS | Buy | Initiate | |
| 2019-06-04 | Citigroup | Neutral | Initiate | |
| 2024-10-16 | B of A Securities | Neutral | Buy | Upgrade |
| 2024-09-24 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-11-21 | Keybanc | Overweight | Overweight | Maintains |
| 2024-11-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-20 | B of A Securities | Buy | Buy | Maintains |
| 2024-08-02 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-08-02 | Keybanc | Overweight | Overweight | Maintains |
| 2024-08-02 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-08 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2024-11-08 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-08 | Keybanc | Overweight | Overweight | Maintains |
| 2025-08-07 | UBS | Buy | Buy | Maintains |
| 2024-11-07 | UBS | Buy | Buy | Maintains |
| 2025-01-10 | Keybanc | Overweight | Overweight | Maintains |
| 2025-01-29 | Citigroup | Buy | Buy | Maintains |
| 2024-10-23 | Citigroup | Buy | Initiate | |
| 2024-12-18 | Citigroup | Buy | Buy | Maintains |
| 2024-08-07 | Argus Research | Buy | Hold | Downgrade |
| 2025-02-07 | Keybanc | Overweight | Overweight | Maintains |
| 2025-02-07 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-02-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-01-28 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-02-11 | B of A Securities | Buy | Buy | Maintains |
| 2024-12-19 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-01-10 | UBS | Buy | Buy | Maintains |
| 2025-05-14 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-11 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-03-31 | Argus Research | Hold | Buy | Upgrade |
| 2025-05-09 | Citigroup | Buy | Buy | Maintains |
| 2025-05-09 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-05-09 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2025-05-09 | Keybanc | Overweight | Overweight | Maintains |
| 2025-01-21 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-14 | Keybanc | Overweight | Overweight | Maintains |
| 2025-03-13 | Goldman Sachs | Buy | Initiate | |
| 2025-05-12 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-10 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-07-09 | UBS | Buy | Buy | Maintains |
| 2025-08-13 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2025-05-08 | UBS | Buy | Buy | Maintains |
| 2025-06-06 | Jefferies | Buy | Buy | Maintains |
| 2025-08-08 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-23 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-15 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-07-14 | Keybanc | Overweight | Overweight | Maintains |
| 2025-07-08 | BMO Capital | Outperform | Outperform | Maintains |
